Grape extract firm Alvinesa Natural Ingredients has acquired leaders in the olive fruit extract space, Genosa, to boost its portfolio of natural upcycled ingredients.
French pharmaceutical company Biocodex has acquired the precision probiotics biotech firm TargEDys in a move set to accelerate its development globally.
TopGum, a global leader in the gummy nutritional supplements space, has signed an agreement to purchase pharmaceutical R&D specialist PharmItBe in a move to advance the company’s development efforts for their nutraceutical range.
Solabia looks set to grow their current active ingredient range after obtaining a majority stake in BioActor, a leading innovator in extracted polyphenol production from fruits and plants with clinically proven health benefits.
Kerry Group, the world’s leading taste and nutrition company, has completed its the reported €126.9 million acquisition of Spanish biotech company Biosearch Life.
Unilever has signed an agreement to acquire Onnit, a Texas-based 'human optimisation' company, as it looks to tap into the growing consumer interest in holistic health and nootropics.
US-based global snacking heavyweight Mondelēz International taps into the mass appeal of protein bars as it acquires a significant majority interest in the UK's leading protein bar brand Grenade.
French renewable energy firm Global EcoPower (GEP) has acquired the spirulina production and marketing assets of Tam, as it continues to harness sustainable agriculture.
Irish nutrition specialist Kerry has completed a deal to buy Pevesa Biotech, as it looks to expand its position as a market leader in non-allergenic and organic plant protein ingredients.
Growing a health and wellness startup company is all about learning how the customer ticks, building trust, creating a community, and collaborating with others to constantly bring the newest innovations to market.
Glanbia Performance Nutrition (GPN) has enjoyed increased revenue so far this year thanks to its €300 million SlimFast acquisition but importing difficulties led to a 'disappointing' like-for-like volume performance, the firm's nine-month...